Researchers closing in on genetic treatments for hereditary lung disease, vision loss
Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.
Read Original Article: Researchers closing in on genetic treatments for hereditary lung disease, vision loss »
